Coronavirus
Viewpoint: Sweden’s unique approach to COVID-19 containment has failed
There was a familiar refrain from political commentators on certain corners of the internet in the early days of the ...
US hospitals have ‘pulled way back’ on hydroxychloroquine use after studies identify safety risks
U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald ...
Top 5 most promising COVID-19 vaccine candidates
More than 100 vaccine efforts are currently underway in the global push to stop the COVID-19 pandemic, according to the ...
Struggling to cope with the COVID-19 pandemic? These apps could help you stay sane
Set a reminder to write down how you’re feeling every day. Now you’ve started a mood diary. These sorts of ...
Why all the COVID-induced blood clots, strokes and heart attacks? The coronavirus may be a blood vessel disease rather than a respiratory affliction
In April, blood clots emerged as one of the many mysterious symptoms attributed to Covid-19, a disease that had initially ...
Is hydroxychloroquine useless and dangerous, or not? Major study released last week dissing therapy now under scrutiny
Does President Trump’s favored coronavirus treatment, the antimalarial drug hydroxychloroquine, make you more likely to die of Covid-19? That was ...
COVID-19 hit the US as early as January, CDC analysis suggests
How early did local transmission of the SARS-CoV-2 virus begin in the United States? For the second time [recently], scientists ...
‘Trial by fire’: How COVID-19 is changing the biotech industry’s relationship with artificial intelligence
AI is currently being used by many companies to identify and screen existing drugs that could be repurposed to treat ...
Adverse reactions in COVID-19 vaccine trial illustrates rocky road to developing therapies for diverse populations
Patients in clinical trials are usually faceless. But as the experimental Covid-19 vaccine being developed by Moderna Therapeutics has begun ...
Infographic: Racing to create affordable at-home test for COVID-19
To stretch beyond the lab, test developers are racing to produce next-stage technologies that could allow for rapid widespread testing ...
Using ‘genomic breadcrumbs’ to track the coronavirus—and predict how to cope with it
Rapid sequencing of viral genomes can help public health officials figure out the origins, spread and nature of quickly moving ...
What’s ‘race’ got to do with it? Sub-Saharan Africa emerges as coronavirus ‘cold spot’, offering clues to develop COVID-19 vaccines
Do diseases discriminate on the basis of 'race'—or their genetic population, using more precise terminology? On the surface, this may ...
Hydroxychloroquine trials halted after World Health Organization cites ‘significantly higher risk of death’ for COVID-19 patients
The World Health Organization has suspended testing of the malaria drug hydroxychloroquine after a study published in The Lancet reported ...
Accidental side effect: COVID-19 pandemic could give polio ‘a fresh start’
The world’s total number of confirmed Covid-19 cases is closing in on 5 million. But an accidental side effect of ...
With a COVID-19 vaccine only a distant possibility, a HIV containment-like strategy could be best option
Though many people are pinning their hopes on a COVID-19 vaccine, another option is available: preventive treatment. At a Senate ...
‘That’s not easy’: Figuring out who gets first shot at a coronavirus vaccine
Even if scientists do develop a safe, broadly effective vaccine, nobody knows how to give it to billions of people ...
Viewpoint: We can’t simply test our way out of the coronavirus pandemic
In response to calls for Covid-19 testing of the entire U.S. population, several large universities, and even some employers, have ...
Viewpoint: Only a tiny percentage of children face threat of severe coronavirus complications. That risk isn’t high enough to justify lockdowns
Horrific stories are emerging of children developing rashes, cardiac abnormalities and other inflammatory symptoms that are linked to the novel ...
New coronavirus test problem: Not enough people seeking tests in some states
Four months into the U.S. coronavirus outbreak, tests for the virus finally are becoming widely available, a crucial step toward ...
Novavax launches human clinical trial on coronavirus vaccine in Australia
A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday [May 26] with hopes ...
Infographic: 8 ways we can defeat the coronavirus
More than 90 vaccines are being developed against SARS-CoV-2 by research teams in companies and universities across the world. Researchers ...
Video: There were objections to Spanish flu lockdowns too. Bad things happened when critics got their way
During the Spanish flu era, officials pushing public health mandates to stop the pandemic in its tracks were met with ...
Exploring coronavirus patient DNA for answers: Why are some people hurt worse than others?
Thousands of UK patients who have fallen ill with coronavirus will have their genomes read in a major study to ...
How coronavirus wreaks havoc on the body, organ by organ
Covid-19 has confounded the expectations of doctors. Patients suffer from a bewildering variety of complications. They urinate blood, complain of ...
Coronavirus survivors’ plasma offers ‘modest’ recovery boost for infected patients, small study suggests
A small study of patients who were severely ill from the coronavirus hints that treatment with antibodies from recovered patients ...
Why evangelical Christians fear—and may reject—a coronavirus vaccine
“Of course,” [Evangelical Christian Laura Popham] said, she’s worried about contracting COVID-19. But she’s more worried about a possible vaccine ...
We need a quick, cheap test for coronavirus antibodies. It also needs to be accurate
An inexpensive coronavirus test that millions of Americans could use at a pharmacy, in a workplace or even at home ...
